To leverage the new wave of enthusiasm, we are thrilled to launch regular Longevity Salons sponsored by 100 Plus Capital to grow a strong community, targeted on onboarding new investors in the space.
100 Plus Capital invests in companies positively impacting human longevity. This can be directly targeted (for example, anti-aging companies) or broader reaching (clean food and water companies).
Please kick off this series with us, join new and old friends over aperitifs, and discuss what fuels the recent optimism in the field.
When: March 5, 2020, 6-9 pm
Where: Quadrus Conference Center, 2400 Sand Hill Road, Menlo Park CA 94025
| PANELISTS |
Investor and Founder, 100 Plus Capital
Sonia Arrison is a best-selling author, analyst, entrepreneur, and investor. She is founder of 100 Plus Capital, co-founder of Unsugarcoat Media (acquired by Medium), and associate founder and advisor to Singularity University in Mountain View, California. Her research focuses on exponentially growing technologies and their impact on society. Her most recent book, 100 Plus: How the Coming Age of Longevity Will Change Everything, From Careers and Relationships to Family and Faith, addresses the social, economic, and cultural impacts of radical human longevity. It gained national best-seller status and keeps Sonia busy speaking all over the world. Sonia is a Board Member at the Thiel Foundation, Foresight Institute, and Woodland School.
Chief Science Officer and Co-founder, SENS Research Foundation
Aubrey de Grey
Dr. de Grey is the biomedical gerontologist who devised the SENS platform, and established SENS Research Foundation to implement it. He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge in 1985 and 2000, respectively. Dr. de Grey is Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations.
Co-Founder and Managing Director, Apollo Ventures
Nils Regge is a serial entrepreneur who co-founded companies with an aggregated valuation over 1bn USD. He was involved in almost 50 financing rounds, co-investments with funds such as Harbourvest, Highland, GFC, Lakestar, Insight Venture Partners, Sofinnova, Loup Ventures and Venbio. Previously Nils was involved with tech companies, but shifted his focus towards biotech and the emerging opportunity of longevity companies. Nils is the co-founder and partner of Apollo Health Ventures (Apollo.vc). All of Apollo’s portfolio companies have raised significant follow on rounds from outside investors.
Angel Investor, Aging Biotech.info
Karl Pfleger, PhD (Stanford CS, Machine Learning) now focuses on aging & longevity after a successful tech career (mySimon, Google). A long-time donor to the Buck Institute and SENS Foundation, he is also an angel investor who has backed over 15 aging-related startups. He is the creator of AgingBiotech.info, a free public resource to track the commercialization progress of the aging biotech sector and related information.
Co-Founder Vium and Health Extension Salons
Joe Betts-Lacroix is the CTO and co-founder of Vium, a translational medicine company focused on improving the success of drug development. Through the creation of more precise and reproducible disease models, Vium’s digital platform provides physiological biomarkers that enable better decisions on which compounds should be advanced to the clinic. Previously, Joe was the primary technical founder of OQO, building the smallest full-featured PC. He has over 80 Patents granted and pending in fields ranging from biophysics and safety systems to thermal systems, and has written numerous peer-reviewed publications in fields such as biophysics, genetics, electronics and robotics. Joe holds a Harvard A.B., MIT S.M. and Caltech research fellowship.
| LIGHTNING TALK SPEAKERS |
CEO and Founder, Occamz Razor
Katharina Sophia Volz is the CEO and founder of OccamzRazor, a startup using machine learning to find treatments for brain aging-related diseases starting with Parkinson’s disease. In partnership with the Stanford AI lab, OccamzRazor built machine learning algorithms that read, extract, and process information from scientific reports and clinical data. OccamzRazor is supported by Nobel Laureate Randy Schekman and is partnering or has received grant funding from leading institutions in Parkinson’s and Machine Learning, which include the Michael J Fox Foundation, the Sergey Brin Family Foundation, and Stanford University.
Katharina will speak on Occamz Razor, and how it can help to advance aging research.
Investor, Elon Life
In the past ten years, Dr. Jiang has been studying and practicing longevity lifestyle. She is also an avid investor in the biotech/longevity space. Her biotech investments focus on anti‐aging/longevity, cancer therapy, vision restoration, medical equipment, and diabetes preventative therapy. Her investments include several IPOs such as Nasdaq ticker symbols (CUE, PRVB, EYE, PLSE) as well as Juvenescence and MAIA. She led the investment of seed round of MAIA in November, 2019.
Hong will give an update on the Landmark Longevity Studies with testing on whole genome sequencing and annotation, telomere lengths, epigenetic clock, inflammation biomarkers, and lipid profiles.
Co-Founder and CEO, Gordian Biotechnology
Francisco is the CEO of Gordian, a therapeutics company pioneering a novel in vivo screening platform to radically increase the efficiency of development for complex diseases of aging.
Francisco will speak on how their novel in vivo screening platform radically improves drug development for complex diseases of aging.
Eli is co-founder at X-Therma, a startup building technology that will end the organ transplant waitlist by making fundamental improvements in the chemistry of preservation. X-Therma developed nature-inspired, novel cryoprotective materials to preserve and recover fully functional organs at sub-zero temperatures without ice damage or adverse toxicity. This technology is a critical enabler and accelerator for other regenerative medicines, especially for large-scale centralized manufacturing of cell and gene therapy, and tissue engineering.
Eli is a lifelong longevity enthusiast, has been involved in several life-extension initiatives and high-profile startups. He will speak about X-Therma’s recent breakthroughs on the way to end the organ transplant waitlist by making fundamental improvements in the chemistry of preservation.
CEO and Co-Founder, Dorian Therapeutics
Dr. Maddalena Adorno is the CEO and co-founder of Dorian Therapeutics, a YC and StartX backed start-up developing new therapeutics to block cellular senescence in a variety of medical conditions. Before starting Dorian, she led research in aging and regenerative medicine at Stanford University. Maddalena has publications in Nature, Cell, and Science and is an inventor on several international patents in oncology and aging.
Maddalena will give an overview of Dorian’s unique approach to preventing and treating diseases of aging.
Managing Partner, Inflection Point Bio
Mr. Keating is currently the managing partner at Inflection Point Bio, providing services to early-stage biotech and longevity companies including strategy, licensing, formation and fundraising. He is also currently executive chairman of Reel Solar Inc., a board member at Innovus Power (Micro-grid controls) and previously at Seebright Inc., a provider of augmented reality software and head-mounted displays. Bill has been CEO or chairman at several companies including NASDAQ listed companies before starting to work closely with several biotech companies that follow the SENS repair model.
Bill willdescribe Oisin, a novel, programmable platform for selectively killing cells, as well as a new nanoparticle delivery mechanism.
| COMMUNITY PARTNERS |
| SCHEDULE |
6 pm Networking
Aperitifs and hors d’oeuvre in the heart of the beautiful Quadrus Conference Center
6.20 pm Panel
Each speaker is invited to give an opening statement on what, if anything, is different now that makes health extension technology such a promising investment opportunity?
Karl Pfleger, Aging Biotech, will speak on the trend of aging companies founded over the last 10 years and his excellent company portfolio overview
Nils Regge, Apollo Ventures, will speak on the role of emerging major VCs in the space and his projections of the industry 5-10 years out
Sonia Arrison, 100 Plus Capital, will speak on her investment philosophy and what societal changes we can expect and invest for now based on her book 100 Plus
Joe Betts-Lacroix, Vium, will speak on the market gap in the longevity industry that entrepreneurs and scientists should tackle when starting longevity companies
Aubrey de Grey, SENS Research Foundation, will speak on what future changes in public policy must go hand-in-hand with increased control of aging
7.00 pm Q&A
The panel is followed by an interactive Q&A between panel and audience:
Investment Tips: Exciting pathways and companies on the horizon — what new investors should know to navigate the space successfully — what warning signs can help distinguish a fountain of youth from snake oil companies
What’s Different: What changes in the investment landscape can we expect in the next 5-10 years — what bottlenecks may halt progress — how can we collaborate to grow a strong ecosystem
What’s Missing: Match-making of scientists + entrepreneurs + funders — mainstream rebuttals to aging trance — realistic and attractive post-aging scenarios
What would you like to know?
7.30 pm Aperitifs with Speakers
Join our speakers for an informal meet and greet, catch up with old friends or make new ones.
8.00 pm Community Announcements
Community Announcements: Short lightning talks from participants who can apply here to share a longevity project, or announcement with the group.
Action items and sign-up to our shared spreadsheet for continued collaboration leading up to the next salons
| PREVIOUS SALONS IN THIS SERIES |
with Aubrey de Grey
Biotech Investing in Longevity
with Mark Katakowski, Sonia Arrison, Sarah Constantin